Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Inventory (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Inventory for 3 consecutive years, with $281000.0 as the latest value for Q4 2025.

  • Quarterly Inventory rose 21.65% to $281000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $281000.0 through Dec 2025, up 21.65% year-over-year, with the annual reading at $281000.0 for FY2025, 21.65% up from the prior year.
  • Inventory for Q4 2025 was $281000.0 at Lexicon Pharmaceuticals, up from $158000.0 in the prior quarter.
  • The five-year high for Inventory was $636000.0 in Q3 2024, with the low at $158000.0 in Q3 2025.
  • Average Inventory over 3 years is $333000.0, with a median of $281000.0 recorded in 2025.
  • The sharpest move saw Inventory skyrocketed 240.12% in 2024, then tumbled 75.16% in 2025.
  • Over 3 years, Inventory stood at $381000.0 in 2023, then plummeted by 39.37% to $231000.0 in 2024, then increased by 21.65% to $281000.0 in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $281000.0, $158000.0, and $168000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.